tiprankstipranks
Trending News
More News >
Promising Potential of Ionis Pharmaceuticals’ Olezarsen in sHTG Market with Competitive Pricing and Strong Market Potential
PremiumRatingsPromising Potential of Ionis Pharmaceuticals’ Olezarsen in sHTG Market with Competitive Pricing and Strong Market Potential
15d ago
Ionis Pharmaceuticals: Promising Market Growth with Tryngolza Approval and Advancing Clinical Trials
Premium
Ratings
Ionis Pharmaceuticals: Promising Market Growth with Tryngolza Approval and Advancing Clinical Trials
15d ago
Ionis Pharmaceuticals price target lowered to $52 from $55 at Morgan Stanley
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $52 from $55 at Morgan Stanley
19d ago
Ionis Pharmaceuticals management to meet with Oppenheimer
PremiumThe FlyIonis Pharmaceuticals management to meet with Oppenheimer
26d ago
Promising Potential of Ionis Pharmaceuticals’ Pelacarsen Drives Buy Rating Amidst Phase 3 HORIZON Trial Optimism
Premium
Ratings
Promising Potential of Ionis Pharmaceuticals’ Pelacarsen Drives Buy Rating Amidst Phase 3 HORIZON Trial Optimism
26d ago
Ionis Pharmaceuticals initiated with a Neutral at Redburn Atlantic
Premium
The Fly
Ionis Pharmaceuticals initiated with a Neutral at Redburn Atlantic
1M ago
Ionis Pharmaceuticals and Ono announce license agreement for sapablursen
PremiumThe FlyIonis Pharmaceuticals and Ono announce license agreement for sapablursen
2M ago
Ionis and AstraZeneca’s WAINZUA gets EU approval for ATTRv-PN treatment
Premium
The Fly
Ionis and AstraZeneca’s WAINZUA gets EU approval for ATTRv-PN treatment
2M ago
Optimistic Future Outlook for Ionis Pharmaceuticals Driven by Robust Growth and Strategic Initiatives
Premium
Ratings
Optimistic Future Outlook for Ionis Pharmaceuticals Driven by Robust Growth and Strategic Initiatives
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100